Show simple item record

dc.contributor.authorForrester, Ian S.
dc.contributor.authorDawes, Anthony
dc.date.accessioned2011-08-10T19:09:56Z
dc.date.available2011-08-10T19:09:56Z
dc.date.issued2008
dc.identifier.urihttp://depot.ceon.pl/handle/123456789/110
dc.description.abstractEuropean competition law, uniquely in the world, attributes high importance, and uses the competition rules, to achieve market integration. In the early years, EC competition decisions punished manufacturers and resellers who contractually inhibited parallel traders. Such actions may have rewarded “free riders” but also helped to create consumer awareness of cross-border shopping opportunities. However, the case of prescription medicines is different.en
dc.language.isoenen
dc.rightsCreative Commons Uznanie autorstwa 3.0 Polskapl_PL
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/pl/legalcode
dc.subjectantitrust lawen
dc.subjectEuropean Unionen
dc.subjectprescription medicinesen
dc.subjectparallel tradeen
dc.titleParallel Trade in Prescription Medicines in the European Union: The Age of Reason?en
dc.typeinfo:eu-repo/semantics/articleen
dc.contributor.organizationUniversity of Glasgowen
dc.contributor.organizationWhite & Case, Brussels
dc.description.epersonMichał Mijal
dc.rights.DELETETHISFIELDinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Creative Commons Uznanie autorstwa 3.0 Polska
Except where otherwise noted, this item's license is described as Creative Commons Uznanie autorstwa 3.0 Polska